- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03471832
Clinical Evaluation of Stenfilcon A Contact Lenses
January 14, 2020 updated by: CooperVision, Inc.
Clinical Evaluation of CooperVision MyDay Lenses
This study is to evaluate the fitting performance of stenfilcon A contact lens (test) compared to narafilcon A contact lens (control).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This study is to evaluate the fitting performance of stenfilcon A contact lens (test) compared to narafilcon A contact lens (control) over 3 hour of wear time in a Japanese population.
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Fukusima
-
Fukushima, Fukusima, Japan, 960-8034
- Shioya eye clinic
-
-
Kyoto
-
Terada, Kyoto, Japan, 610-0121
- Kodama Eye Clinic
-
-
Tokyo
-
Shibuya, Tokyo, Japan, 15-0043
- Itoi Eye Clinic
-
-
Yamaguchi
-
Shimonoseki, Yamaguchi, Japan, 751-0872
- Ueda Eye Clinic
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
A person is eligible for inclusion in the study if he/she:
- Is Japanese
- Has had a self-reported oculo-visual examination in the last two years.
- Is at least 18 years of age and has full legal capacity to volunteer.
- Has read and understood the informed consent letter.
- Is willing and able to follow instructions and maintain the appointment schedule.
- Is correctable to a visual acuity of 20/40 or better (in each eye) with their habitual vision correction or 20/20 best-corrected.
- Currently wears soft contact lenses.
- Has clear corneas and no active ocular disease.
Exclusion Criteria:
A person will be excluded from the study if he/she:
- Has never worn contact lenses before.
- Has any systemic disease affecting ocular health.
- Is using any systemic or topical medications that will affect ocular health.
- Has any ocular pathology or severe insufficiency of lacrimal secretion (moderate to severe dry eyes) that would affect the wearing of contact lenses.
- Has persistent, clinically significant corneal or conjunctival staining using sodium fluorescein dye.
- Has any clinically significant lid or conjunctival abnormalities, active neovascularization or any central corneal scars.
- Is aphakic.
- Has undergone corneal refractive surgery.
- Is participating in any other type of eye related clinical or research study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: stenfilcon A lens
MyDay contact lens
|
contact lens
Other Names:
|
|
Active Comparator: narafilcon A lens
1-Day Acuvue TruEye
|
contact lens
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Lens Movement
Time Frame: 5 minutes
|
Movement of lens after blink: (Categories = Tight, Slightly tight, Optimum, Slightly loose, Loose)
|
5 minutes
|
|
Lens Movement
Time Frame: 3hrs
|
Movement of lens after blink: (Categories = Tight, Slightly tight, Optimum, Slightly loose, Loose)
|
3hrs
|
|
Horizontal Lens Centration
Time Frame: 5 minutes
|
Centration of lens horizontally: (Grades = Temporal, Slightly temporal, Centered, Slightly Nasal, Nasal)
|
5 minutes
|
|
Horizontal Lens Centration
Time Frame: 3hrs
|
Centration of lens horizontally: (Grades = Temporal, Slightly temporal, Centered, Slightly Nasal, Nasal)
|
3hrs
|
|
Vertical Lens Centration
Time Frame: 5 minutes
|
Centration of lens horizontally: (Grades = Superior, Slightly superior, Center, Slightly inferior, Inferior)
|
5 minutes
|
|
Vertical Lens Centration
Time Frame: 3hrs
|
Centration of lens horizontally: (Grades = Superior, Slightly superior, Centered, Slightly inferior, Inferior)
|
3hrs
|
|
Corneal Coverage
Time Frame: 5 minutes
|
Does lens cover the cornea: (Yes, No)
|
5 minutes
|
|
Corneal Coverage
Time Frame: 3hrs
|
Does lens cover the cornea: (Yes, No)
|
3hrs
|
|
Lens Lag
Time Frame: 5 minutes
|
Movement after looking right and left: (Grades = Move along with cornea, slight delay, delay)
|
5 minutes
|
|
Lens Lag
Time Frame: 3hrs
|
Movement after looking right and left: (Grades = Move along with cornea, slight delay, delay)
|
3hrs
|
|
Overall Fitting Performance
Time Frame: 5 minutes
|
Lens fit performance: (Grades: Optimum, Good, Acceptable, Unacceptable)
|
5 minutes
|
|
Overall Fitting Performance
Time Frame: 3hrs
|
Lens fit performance: (Grades: Optimum, Good, Acceptable, Unacceptable)
|
3hrs
|
|
Investigator Fit Preference
Time Frame: 5 minutes
|
Lens fit preference: (Grades: Prefer stenfilcon A strongly, Prefer stenfilcon A slightly, Either, Prefer narafilcon A slightly, Prefer narafilcon A strongly)
|
5 minutes
|
|
Investigator Fit Preference
Time Frame: 3hrs
|
Lens fit preference: (Grades: Prefer stenfilcon A strongly, Prefer stenfilcon A slightly, Either, Prefer narafilcon A slightly, Prefer narafilcon A strongly)
|
3hrs
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Comfort
Time Frame: Baseline
|
Subjective comfort: (on a scale of 0-10, 0 (Uncomfortable) - 10 (Comfortable))
|
Baseline
|
|
Comfort
Time Frame: 5 Minutes
|
Subjective comfort: (on a scale of 0-10, 0 (Uncomfortable) - 10 (Comfortable))
|
5 Minutes
|
|
Comfort
Time Frame: 3 hours
|
Subjective comfort: (on a scale of 0-10, 0 (Uncomfortable) - 10 (Comfortable))
|
3 hours
|
|
Dryness
Time Frame: Baseline
|
Subjective dryness: (on a scale of 0-10, 0 (Dry) - 10 (Not dry))
|
Baseline
|
|
Dryness
Time Frame: 5 minutes
|
Subjective dryness: (on a scale of 0-10, 0 (Dry) - 10 (Not dry))
|
5 minutes
|
|
Dryness
Time Frame: 3 hours
|
Subjective dryness: (on a scale of 0-10, 0 (Dry) - 10 (Not dry))
|
3 hours
|
|
Stinging/Burning
Time Frame: Baseline
|
Subjective stinging/burning sensation: (on a scale of 0-10, 0 (Cannot wear) - 10 (No Stinging/Burning))
|
Baseline
|
|
Stinging/Burning
Time Frame: 5 minutes
|
Subjective stinging/burning sensation: (on a scale of 0-10, 0 (Cannot wear) - 10 (No Stinging/Burning))
|
5 minutes
|
|
Stinging/Burning
Time Frame: 3 hours
|
Subjective stinging/burning sensation: (on a scale of 0-10, 0 (Cannot wear) - 10 (No Stinging/Burning))
|
3 hours
|
|
Edge/Lens Awareness
Time Frame: Baseline
|
Subjective edge/lens awareness: (on a scale of 0-10, 0 (Cannot wear) - 10 (No edge awareness))
|
Baseline
|
|
Edge/Lens Awareness
Time Frame: 5 minutes
|
Subjective edge/lens awareness: (on a scale of 0-10, 0 (Cannot wear) - 10 (No edge awareness))
|
5 minutes
|
|
Edge/Lens Awareness
Time Frame: 3 hours
|
Subjective edge/lens awareness: (on a scale of 0-10, 0 (Cannot wear) - 10 (No edge awareness))
|
3 hours
|
|
Subjective Lens Preference
Time Frame: Baseline
|
Lens preference (stenfilcon A, Either, Neither, narafilcon A)
|
Baseline
|
|
Subjective Lens Preference
Time Frame: 5 minutes
|
Lens preference (stenfilcon A, Either, Neither, narafilcon A)
|
5 minutes
|
|
Subjective Lens Preference
Time Frame: 3 hours
|
Lens preference (stenfilcon A, Either, Neither, narafilcon A)
|
3 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Yuji Kodama, MD, PhD, Kodama Eye Clinic
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 3, 2018
Primary Completion (Actual)
April 25, 2018
Study Completion (Actual)
April 25, 2018
Study Registration Dates
First Submitted
March 14, 2018
First Submitted That Met QC Criteria
March 19, 2018
First Posted (Actual)
March 21, 2018
Study Record Updates
Last Update Posted (Actual)
January 29, 2020
Last Update Submitted That Met QC Criteria
January 14, 2020
Last Verified
January 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- JP-MKTG-201709_02
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myopia
-
Tianjin Medical University Eye HospitalNot yet recruitingProgressive Myopia | Pediatric Myopia | Orthokeratology-related Myopia Progression
-
Shanghai General Hospital, Shanghai Jiao Tong University...Not yet recruitingMyopia | Myopia, ProgressiveChina
-
SightGlass Vision, Inc.Recruiting
-
University of FaisalabadCompletedRefractive Errors | Myopia | Progressive MyopiaPakistan
-
SightGlass Vision, Inc.RecruitingMyopia | Myopia Progression | Juvenile MyopiaUnited States
-
Shanghai Eye Disease Prevention and Treatment CenterEnrolling by invitationMyopia, Child Myopia ProgressionChina
-
He Eye HospitalNot yet recruiting
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityActive, not recruiting
-
University Eye Hospital, FreiburgActive, not recruiting
-
University of BradfordUniversity of Huddersfield; CooperVision International Limited (CVIL)Enrolling by invitationMyopia, ProgressiveUnited Kingdom
Clinical Trials on stenfilcon A lens
-
CooperVision, Inc.CompletedMyopiaUnited States
-
CooperVision International Limited (CVIL)Centre for Ocular Research & Education, CanadaCompletedAstigmatism | Myopia | HyperopiaCanada
-
CooperVision, Inc.Completed
-
CooperVision International Limited (CVIL)Not yet recruiting
-
CooperVision International Limited (CVIL)University of California, BerkeleyRecruiting
-
CooperVision, Inc.Completed
-
CooperVision, Inc.CompletedAstigmatismUnited Kingdom
-
CooperVision International Limited (CVIL)Indiana UniversityNot yet recruiting
-
CooperVision, Inc.Centre for Ocular Research & Education, CanadaCompleted
-
CooperVision International Limited (CVIL)Centre for Ocular Research & Education, CanadaCompletedMyopia | AmetropiaCanada